Congrats to the Statler family in Fairhope, AL on reaching their fundraising goal for their new accessible vehicle! Brothers Raylee Odom, 22-years-old, and Christian Cumbie, 18-years-old, both live with Duchenne muscular dystrophy. The Statler family applied to the Jett Giving Fund because of how costly it is to provide a safe and reliable form of transportation for two handicapped children on top of other medical expenses.
Raylee and Christian’s needs required both young men to move into power wheelchairs as pre-teens. As they have had to move up to larger wheelchairs, reliable transportation has become even more crucial. Not having an accessible vehicle has resulted in lack of room for the boys to sit in safe positions and fit comfortably.
The Jett Giving Fund program is meant to support families impacted by Duchenne, and assist them in raising funds for accessible vehicles. Families raise half the funds needed for the cost of the equipment or more, and Jett Foundation covers the remaining cost for families accepted into the program.
“Not having good transportation has really hindered our ability to do things freely,” says mom, Carissa. They are looking most forward to having reliable and safe transportation to get them to their doctor appointments and school. Not having to worry about how, will take a huge weight off their shoulders.”
They are looking forward to family trips as well! The boys love spending time with family and friends, exploring new places, trying out different restaurants, playing video games, attending concerts, and meeting their favorite tv and movie characters.
“I hope any and all families that are impacted by Duchenne would use The Jett Foundation as a resource. You have truly changed our lives,” Carissa says.
Established in 2017, Jett Giving Fund has helped transform the lives of countless families across the country with over $1.8 million worth of accessible equipment and emergency assistance thanks to the generous support of individual donors, local communities, and major sponsors including Cure Dale’s Duchenne, Sarepta Therapeutics, FibroGen, the Flatley Foundation, and the Killian Family.